"Methylnitrosourea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.
| Descriptor ID |
D008770
|
| MeSH Number(s) |
D02.654.692.480 D02.948.594.490
|
| Concept/Terms |
Methylnitrosourea- Methylnitrosourea
- Nitrosomethylurea
- N-Methyl-N-nitrosourea
- N Methyl N nitrosourea
|
Below are MeSH descriptors whose meaning is more general than "Methylnitrosourea".
Below are MeSH descriptors whose meaning is more specific than "Methylnitrosourea".
This graph shows the total number of publications written about "Methylnitrosourea" by people in this website by year, and whether "Methylnitrosourea" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methylnitrosourea" by people in Profiles.
-
Arumugam A, Agullo P, Boopalan T, Nandy S, Lopez R, Gutierrez C, Narayan M, Rajkumar L. Neem leaf extract inhibits mammary carcinogenesis by altering cell proliferation, apoptosis, and angiogenesis. Cancer Biol Ther. 2014 Jan; 15(1):26-34.
-
Khazal KF, Samuel T, Hill DL, Grubbs CJ. Effect of an extract of Withania somnifera root on estrogen receptor-positive mammary carcinomas. Anticancer Res. 2013 Apr; 33(4):1519-23.
-
Thordarson G, Semaan S, Low C, Ochoa D, Leong H, Rajkumar L, Guzman RC, Nandi S, Talamantes F. Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments. Breast Cancer Res Treat. 2004 Oct; 87(3):277-90.
-
Thordarson G, Slusher N, Leong H, Ochoa D, Rajkumar L, Guzman R, Nandi S, Talamantes F. Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway. Breast Cancer Res. 2004; 6(4):R423-36.
-
Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S. Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Res. 2004; 6(1):R31-7.
-
Thordarson G, Lee AV, McCarty M, Van Horn K, Chu O, Chou YC, Yang J, Guzman RC, Nandi S, Talamantes F. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Carcinogenesis. 2001 Dec; 22(12):2039-47.
-
Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S. Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci U S A. 2001 Sep 25; 98(20):11755-9.
-
Thordarson G, Van Horn K, Guzman RC, Nandi S, Talamantes F. Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones. Carcinogenesis. 2001 Jul; 22(7):1027-33.
-
Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S. Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci U S A. 1999 Mar 02; 96(5):2520-5.
-
Abrams TJ, Guzman RC, Swanson SM, Thordarson G, Talamantes F, Nandi S. Changes in the parous rat mammary gland environment are involved in parity-associated protection against mammary carcinogenesis. Anticancer Res. 1998 Nov-Dec; 18(6A):4115-21.